K12CA086913 Renewal - Paul Calabresi Award in Clinical Oncology Research

K12CA086913 续展 - Paul Calabresi 临床肿瘤学研究奖

• 批准号: 9336792
• 负责人: MADELEINE A. KANE
• 金额: $ 109.78万
• 依托单位: UNIVERSITY OF COLORADO DENVER
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-09-18 至 2019-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9336792
• 关键词: Advisory Committees; Applications Grants; Award; Basic Science; Cancer Research Project; Clinical; Clinical Oncology; Clinical Research; Clinical Sciences; Colorado; Communication; Discipline; Doctor of Philosophy; Ensure; Epidemiologist; Faculty; Fostering; Foundations; Funding; Future; Individual; Laboratories; Lead; Learning; Malignant Neoplasms; Medical; Medical Oncology; Mentors; Mentorship; NCI Scholars Program; Nurses; Oral Surgeon; Peer Review; Pharmacists; Pharmacology; Program Development; Psychologist; Publications; Research; Research Personnel; Schools; Scientist; Training; Training Programs; United States National Institutes of Health; Universities; anticancer research; cancer clinical trial; career; design; flexibility; member; multidisciplinary; personalized cancer therapy; professor; programs; responsible research conduct; role model; success

DESCRIPTION (provided by applicant): The purpose of this Paul Calabresi Award in Clinical Oncology Research (PCACOR) is to prepare highly qualified cancer clinical researchers called Scholars who can independently design, manage and complete cancer clinical trials by learning to communicate and coordinate with multidisciplinary teams of clinical and basic scientists using state-of-the-art laboratory analyses to personalize cancer treatment. Specific objectives are to: 1) Provide a flexible Individual Development Program for oncology medical doctors and Ph.D. clinicians (nurses, pharmacists, clinical psychologists, epidemiologists, oral surgeons) who have completed their clinical training and basic research scientists who are committed to a translational clinical cancer research career in an academic setting; 2) Foster interdisciplinary training, communication and interaction through multiple mentoring of program scholars; 3) Create an ongoing mentorship to the completed PCACOR Scholars to ensure their successful transition to clinical research independence. Strong clinical and basic science mentors provide exceptional training and role models in all oncology clinical disciplines as well in cancer basic science. A multidisciplinary Advisory Committee oversees the PCACOR directed by Program Leaders, Madeleine A. Kane, MD, Ph.D., Professor of Medical Oncology, and Andrew Thorburn, Ph.D., Professor and Chair, Department of Pharmacology, Deputy Director, UCCC. Training period lasts from two to seven years and includes Core requirements such as Responsible Conduct of Research and coursework provided by CCTSI Clinical Science Program and the UCD Graduate School. Each Scholar completes a basic science project and also designs at least one cancer clinical trial. Scholars submit an NIH style grant application within the last yea of training. The ultimate success is demonstrated by our track record. A total of fifteen junior faculty have trained as PCACOR Scholars, nine during the current funding period (out of 42 applications). Thirteen Scholars remain faculty members at University of Colorado Denver Anschutz Medical Campus (UCD-AMC); six have been promoted, all have multiple peer-reviewed publications, both clinical and basic science. Eight have obtained peer-reviewed funding from NIH, DOD ACS and/or Komen Foundation. All have designed at least one cancer clinical trial, and several PCACOR graduates lead national cancer clinical trials, cancer research training programs and clinical cancer research programs. Our PCACOR successfully produces the translational cancer clinical researchers of the future.

描述（由申请人提供）：该Paul Calabresi临床肿瘤学研究奖（PCACOR）的目的是培养高素质的癌症临床研究人员，称为学者，他们可以通过学习与临床和基础科学家的多学科团队进行沟通和协调，独立设计，管理和完成癌症临床试验。具体目标是：1）为肿瘤学医生和博士提供灵活的个人发展计划。临床医生（护士，药剂师，临床心理学家，流行病学家，口腔外科医生）谁已经完成了他们的临床培训和基础研究科学家谁致力于在学术环境中的转化临床癌症研究生涯; 2）通过多个项目学者的指导促进跨学科的培训，沟通和互动; 3）为完成PCACOR奖学金的学生提供持续的指导，以确保他们成功过渡到临床研究独立。强大的临床和基础科学导师在所有肿瘤学临床学科以及癌症基础科学方面提供卓越的培训和榜样。一个多学科咨询委员会监督PCACOR由项目领导人马德琳A。凯恩，医学博士，哲学博士，医学肿瘤学教授和Andrew Thorburn博士，UCCC药理学系教授、系主任、副主任。培训期持续两到七年，包括核心要求，如研究的负责任行为和课程由CCTSI临床科学计划和UCD研究生院提供。每个学者完成一个基础科学项目，并设计至少一个癌症临床试验。学者们在培训的最后一是的提交一份NIH式的资助申请。我们的业绩记录证明了我们最终的成功。共有15名初级教师接受了PCACOR学者的培训，其中9人在当前资助期间（42份申请中）。13名学者仍然是科罗拉多丹佛安舒茨医学院（UCD-AMC）的教师;六人已经晋升，所有人都有多个同行评审的出版物，包括临床和基础科学。其中8个获得了NIH、DOD ACS和/或科门基金会的同行评审资助。所有人都设计了至少一个癌症临床试验，几个PCACOR毕业生领导国家癌症临床试验，癌症研究培训计划和临床癌症研究计划。我们的PCACOR成功地培养了未来的转化癌症临床研究人员。